Characterization of Extracellular GABA in the Substantia Nigra Reticulata by Means of Brain Microdialysis

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1992 Jun 1

PMID 1635589

Citations 5

Authors

W Timmerman

J Zwaveling

B H Westerink

Affiliations

Soon will be listed here.

Abstract

Brain microdialysis was used to characterize extracellular gamma-aminobutyric acid (GABA) in the substantia nigra reticulata (SNR) of freely moving rats. The extracellular GABA in the SNR was characterized using acutely implanted probes (4-8 h after surgery; day 1) and chronically implanted probes (24 h after surgery; day 2). 3-Mercaptopropionic acid, a glutamic acid decarboxylase inhibitor, was used to identify GABA. This drug induced an immediate decrease in the extracellular GABA levels to 40% of basal values, suggesting that the detected GABA is, at least in part, newly synthesized. The basal levels of extracellular GABA measured either on day 1 or day 2 were not affected by infusion of micromolar amounts of tetrodotoxin. Therefore, a direct coupling between GABA dialysate concentrations and nerve-impulse flow does not seem to exist. Infusion of the GABA uptake inhibitor nipecotic acid (0.5 mmol/l) resulted in a 4-fold increase in the dialysate levels of GABA lasting at least for 3 h on both days. K+ stimulation (60 mmol/l) increased extracellular GABA levels in the SNR to 450% of basal values. This effect again did not differ significantly on day 1 and day 2. The origin of the extracellular GABA in the SNR, as recorded by microdialysis under the two experimental conditions, is discussed.

Citing Articles

GABAergic transmission in rat pontine reticular formation regulates the induction phase of anesthesia and modulates hyperalgesia caused by sleep deprivation.

Vanini G, Nemanis K, Baghdoyan H, Lydic R Eur J Neurosci. 2014; 40(1):2264-73.

PMID: 24674578 PMC: 4107042. DOI: 10.1111/ejn.12571.

Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Watson C, Soto-Calderon H, Lydic R, Baghdoyan H Sleep. 2008; 31(4):453-64.

PMID: 18457232 PMC: 2279760. DOI: 10.1093/sleep/31.4.453.

An investigation into the pharmacokinetics of 3-mercaptopropionic acid and development of a steady-state chemical seizure model using in vivo microdialysis and electrophysiological monitoring.

Crick E, Osorio I, Bhavaraju N, Linz T, Lunte C Epilepsy Res. 2007; 74(2-3):116-25.

PMID: 17382519 PMC: 2474737. DOI: 10.1016/j.eplepsyres.2007.02.003.

Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids.

Hutchinson P, OConnell M, Al-Rawi P, Gupta A, Maskell L, Pickard J J Neurol Neurosurg Psychiatry. 2002; 72(1):99-105.

PMID: 11784833 PMC: 1737714. DOI: 10.1136/jnnp.72.1.99.

An investigation of the origin of extracellular GABA in rat nucleus accumbens measured in vivo by microdialysis.

Smith S, Sharp T J Neural Transm Gen Sect. 1994; 97(2):161-71.

PMID: 7873125 DOI: 10.1007/BF01277951.

References

Giralt M, Bonanno G, Raiteri M . GABA terminal autoreceptors in the pars compacta and in the pars reticulata of the rat substantia nigra are GABAB. Eur J Pharmacol. 1990; 175(2):137-44. DOI: 10.1016/0014-2999(90)90224-t. View

van der Heyden J, Venema K, Korf J . In vivo release of endogenous GABA from rat substantia nigra measured by a novel method. J Neurochem. 1979; 32(2):469-76. View

Waldmeier P, Wicki P, Feldtrauer J, Baumann P . Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors. Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(4):372-8. DOI: 10.1007/BF00167037. View

Moghaddam B, Bunney B . Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem. 1989; 53(2):652-4. DOI: 10.1111/j.1471-4159.1989.tb07383.x. View

Santiago M, Westerink B . Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(4):407-14. DOI: 10.1007/BF00169457. View

van der Heyden J, Venema K, Korf J . In vivo release of endogenous gamma-aminobutyric acid from rat striatum: effects of muscimol, oxotremorine, and morphine. J Neurochem. 1980; 34(6):1648-53. DOI: 10.1111/j.1471-4159.1980.tb11256.x. View

Oertel W, Schmechel D, Brownstein M, Tappaz M, Ransom D, Kopin I . Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum. J Histochem Cytochem. 1981; 29(8):977-80. DOI: 10.1177/29.8.7024401. View

Fonnum F, Gottesfeld Z, GROFOVA I . Distribution of glutamate decarboxylase, choline acetyl-transferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res. 1978; 143(1):125-38. DOI: 10.1016/0006-8993(78)90756-4. View

Osborne P, OConnor W, Drew K, Ungerstedt U . An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats. J Neurosci Methods. 1990; 34(1-3):99-105. DOI: 10.1016/0165-0270(90)90047-j. View

10.

Westerink B, Hofsteede H, Damsma G, DE VRIES J . The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(4):373-8. DOI: 10.1007/BF00169526. View

11.

Drew K, OConnor W, Kehr J, Ungerstedt U . Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur J Pharmacol. 1990; 187(3):385-97. DOI: 10.1016/0014-2999(90)90366-e. View

12.

Brownstein M, Mroz E, Tappaz M, Leeman S . On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Res. 1977; 135(2):315-23. DOI: 10.1016/0006-8993(77)91034-4. View

13.

Arbilla S, Kamal L, Langer S . Presynaptic GABA autoreceptors on GABAergic nerve endings of the rat substantia nigra. Eur J Pharmacol. 1979; 57(2-3):211-7. DOI: 10.1016/0014-2999(79)90367-4. View

14.

Kehr J, Ungerstedt U . Fast HPLC estimation of gamma-aminobutyric acid in microdialysis perfusates: effect of nipecotic and 3-mercaptopropionic acids. J Neurochem. 1988; 51(4):1308-10. DOI: 10.1111/j.1471-4159.1988.tb03101.x. View

15.

Drew K, OConnor W, Kehr J, Ungerstedt U . Characterization of gamma-aminobutyric acid and dopamine overflow following acute implantation of a microdialysis probe. Life Sci. 1989; 45(14):1307-17. DOI: 10.1016/0024-3205(89)90134-3. View

16.

Waldmeier P, Wicki P, Feldtrauer J, Baumann P . Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337(3):289-95. DOI: 10.1007/BF00168841. View

17.

Girault J, Spampinato U, Savaki H, Glowinski J, Besson M . In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents. Neuroscience. 1986; 19(4):1101-8. DOI: 10.1016/0306-4522(86)90126-0. View

18.

Bourdelais A, Kalivas P . Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res. 1990; 516(1):132-6. DOI: 10.1016/0006-8993(90)90907-s. View

19.

Oertel W, Mugnaini E . Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci Lett. 1984; 47(3):233-8. DOI: 10.1016/0304-3940(84)90519-6. View

20.

Nagy J, Carter D, Fibiger H . Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection. Brain Res. 2011; 158(1):15-29. DOI: 10.1016/0006-8993(78)90003-3. View